Partial Beclin 1 silencing aggravates doxorubicin- and Fas-induced apoptosis in HepG2 cells

doi:10.3748/wjg.v12.i18.2895

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 18

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2929)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series.

Item

Count

PDF

322

HTML

2394

Figures (1-7)

213

Sum=2929

May 14, 2006 (publication date) through Jul 7, 2024

Times Cited of This Article

Times Cited (27)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. May 14, 2006; 12(18): 2895-2900
Published online May 14, 2006. doi: 10.3748/wjg.v12.i18.2895

Full Size Figure Download Figure

Figure 6 Assessment of cytochrome c release in HepG2 cells after siRNA transfection and treatment with an agonistic anti-Fas antibody or doxorubicin.

Citation: Daniel F, Legrand A, Pessayre D, Vadrot N, Descatoire V, Bernuau D. Partial Beclin 1 silencing aggravates doxorubicin- and Fas-induced apoptosis in HepG2 cells. World J Gastroenterol 2006; 12(18): 2895-2900
URL: https://www.wjgnet.com/1007-9327/full/v12/i18/2895.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i18.2895